Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study

Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study

Abstract Background Granulocyte and monocyte adsorptive apheresis (GMA) is widely used as a remission induction therapy for active ulcerative colitis (UC) patients. However, there are no available biomarkers for predicting the clinical outcome of GMA. We investigated the utility of Fecal calprotecti...

Full description

Bibliographic Details
Main Authors: Nobuhiro Ueno, Yuya Sugiyama, Yu Kobayashi, Yuki Murakami, Takuya Iwama, Takahiro Sasaki, Takehito Kunogi, Keitaro Takahashi, Kazuyuki Tanaka, Katsuyoshi Ando, Shin Kashima, Yuhei Inaba, Kentaro Moriichi, Hiroki Tanabe, Masaki Taruishi, Yusuke Saitoh, Toshikatsu Okumura, Mikihiro Fujiya
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Gastroenterology
Subjects:
Fecal calprotectin
Ulcerative colitis
Biomarker
Granulocyte/Monocyte Apheresis (GMA)
Endoscopic remission
Clinical remission
Online Access:https://doi.org/10.1186/s12876-021-01889-0

Similar Items

Similar Items